Showing results (301-310 of 383) with videos related to
Sort By:
Pageof 39
The American Journal of the Medical Sciences|March 1, 1991
Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarctionL Ngo, D L Vesely, J K Bissett, et al.Science Advances|February 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypesYi Sun, Georgia F Papadaki, Christine A Devlin, et al.Thrombosis Research|December 26, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulationJoseph A Jakubowski, Chunmei Zhou, Stipo Jurcevic, et al.Journal of Cardiovascular Pharmacology|April 7, 2007
Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjectsJoseph A Jakubowski, Christopher D Payne, Govinda J Weerakkody, et al.Journal of Cardiovascular Pharmacology|April 25, 2006
The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjectsJoseph A Jakubowski, Christopher D Payne, John T Brandt, et al.European Heart Journal|May 12, 2009
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery diseaseChristoph Varenhorst, Stefan James, David Erlinge, et al.Journal of Thrombosis and Haemostasis : JTH|September 29, 2007
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJ T Brandt, S L Close, S J Iturria, et al.Platelets|March 1, 2012
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrelIsabell Bernlochner, Tanja Morath, Patricia B Brown, et al.Drugs & Aging|September 5, 2009
Effect of age on the pharmacokinetics and pharmacodynamics of prasugrel during multiple dosing: an open-label, single-sequence, clinical trialDavid S Small, Rebecca E Wrishko, C Steven Ernest, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.Pageof 39